cyproplex 50 mg tablet
teva pharmaceuticals (pty) ltd - tablet - see ingredients - each tablet contains cyproterone acetate 50,0 mg
proplex greaseless muscle rub- menthol, unspecified form and methyl salicylate cream
natureplex llc - menthol 10% methyl salicylate 15% - topical analgesic topical analgesic temporarily relieves minor aches and pains of muscles and joints
proplex bacitracin- bacitracin cream
natureplex llc - bacitracin (unii: 58h6rwo52i) (bacitracin - unii:58h6rwo52i) - first aid antibiotic first aid to help prevent infection in: - minor cuts - scrapes - burns
proplex lidocaine- lidocaine cream
natureplex llc - lidocaine (unii: 98pi200987) (lidocaine - unii:98pi200987) - topical analgesic for the temporary relief of pain associated with minor burns, sunburn, minor cuts, scrapes, insect bites, and minor skin irritations
cycoplex liquid
nabin laboratory (unani) - sharbat mavez - liquid
cyroplex tablet
therapeutic foods co. - ascorbic acid; thiamine mononitrate; pyridoxine hydrochloride; vitamin a; vitamin d - tablet - 15mg; 1mg; .5mg; 1500unit; 60unit - ascorbic acid 15mg; thiamine mononitrate 1mg; pyridoxine hydrochloride .5mg; vitamin a 1500unit; vitamin d 60unit - multivitamin preparations
caprolex injection
techno drugs ltd. - aminocaproic acid - injection - 1 gm/5ml
proplex t injection
adcock ingram critical care (pty) ltd - injection - see ingredients - each 30 ml solution contains factor ix 500 iu
caprolex injection
techno drugs ltd., gazipur - aminocaproic acid - injection - 1 gm/5ml
prothromplex total 600 iu powder and solvent for solution for injection
baxalta innovations gmbh - human coagulation factor ii; human coagulation factor vii; human coagulation factor ix; human coagulation factor x; protein c - powder and solvent for solution for injection - 600 international unit(s) - blood coagulation factors; coagulation factor ix, ii, vii and x in combination - antihemorrhagics, coagulation factors ix, ii, vii and x in combination - treatment of bleeding and perioperative prophylaxis of bleeding in acquired deficiency of prothrombin complex coagulation factors, such as a deficiency caused by treatment with vitamin k antagonists or in case of overdose with vitamin k antagonists, when rapid correction of the deficiency is required. treatment and perioperative prophylaxis of hemorrhages in congenital deficiency of vitamin k-dependent coagulation factors, when purified specific coagulation factor concentrate is not available.